IF by specialty › Oncology
Nature Reviews Clinical Oncology — Impact Factor
The 2025 Impact Factor of Nature Reviews Clinical Oncology is 94.6 (Q1 in Oncology; subscription or hybrid).
- Impact Factor
- 94.6 JCR 2025
- JCR category
- Oncology
- Quartile
- Q1 in Oncology
- Publisher
- Springer Nature
- Open access
- subscription or hybrid
- IF source
- bioxbio.com
Position within the field
Ranked 2 of the 42 journals in Oncology on this site (top 10%).
Oncology journals with a similar Impact Factor
- Annals of Oncology IF 80.4
- Nature Reviews Cancer IF 60.7
- Cancer Cell IF 56.1
- Journal of Clinical Oncology IF 44.7
- Molecular Cancer IF 42.2
- Lancet Oncology IF 33.7
About this value
The Journal Impact Factor of Nature Reviews Clinical Oncology (JCR 2025, released June 2026) is 94.6. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Oncology.